Gilead analysis shows remdesivir reduced coronavirus death risk, more studies needed
Gilead Sciences Inc said on Friday an analysis showed its antiviral remdesivir helped reduce the risk of death in severely ill Covid-19 patients, but cautioned that rigorous clinical trials were neede...
সম্পূর্ণ আর্টিকেলটি পড়ুন
We use cookies to ensure you get the best experience on our website.